Key Highlights
- Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to receive essential medical care on an outpatient basis and who are homebound due to circumstances. Market value represents the total spending on home healthcare services within a given year.
- The Asia-Pacific home healthcare market recorded revenues of $83.56 billion in 2024, representing a compound annual growth rate (CAGR) of 7.7% between 2019 and 2024.
- The services segment accounted for the market's largest proportion in 2024, with total revenues of $69.86 billion, equivalent to 83.6% of the market's overall value.
- Asia-Pacific accounted for 20.2% of the global home healthcare market in 2024.
Report Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the home healthcare market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the home healthcare market in Asia-Pacific
- Leading company profiles reveal details of key home healthcare market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific home healthcare market with five year forecasts
Reasons to Buy
- What was the size of the Asia-Pacific home healthcare market by value in 2024?
- What will be the size of the Asia-Pacific home healthcare market in 2029?
- What factors are affecting the strength of competition in the Asia-Pacific home healthcare market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's home healthcare market?
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Fresenius Medical Care AG & Co KGaA
- Koninklijke Philips NV
- Ramsay Health Care Ltd
- Medtronic Plc

